Nick shares his insights on the pressing challenges facing the U.S. healthcare market and how Philips is transforming patient care through advanced data analytics, diagnostics, and remote monitoring.

Kimpen — a specialist in respiratory diseases — has been Chief Medical Officer of Philips since 2016. He is ultimately responsible for patient safety. Kimpen will be monitoring Project Uno ...

Philips announced the first U.S. treatment using its new laser device that combines two peripheral artery disease (PAD) procedures into one.

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG ... enhance procedural efficiency and improve patient outcomes for interventional procedures – bringing better care to more people.

Dutch medtech giant Philips has announced that it has enrolled the first patient in its THOR IDE clinical trial set to study the company’s combined laser atherectomy and intravascular ...

Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...

November 12, 2024Designed specifically for use in radiation oncology, new Spectral CT 7500 RT enables personalized radiation therapy planning to ...

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease GlobeNewswire November 04, 2024 With a unique world-first ability to ...

Detailed price information for Koninklijke Philips Electronics ADR (PHG-N) from The Globe and Mail including charting and trades.

Philips' patient- and people-centric innovation leverages advanced ... ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 ...